Atherosclerotic renovascular disease: Medica therapy versus medical therapy plus renal artery stenting in preventing renal failure progression. The rationale and study design of a prospective, multicenter and randomized trial (INTER)

Journal of Nephrology

Volumn 18, Issue 4, 2005, Pages 423-428

  Scarpioni, Roberto ^a   Michieletti, Emanuele ^a   Cristinelli, Luciano ^a   Ugolotti, Ugo ^a   Scolari, Francesco ^b   Ventrurelli, Chiara ^b   Cancarini, Giovanni ^b   Pecchini, Paola ^c   Malberti, Fabio ^c   Maroldi, Roberto ^d   Rozzi, Gabriele ^c   Olivetti, Lucio ^c  

^a Guglielmo da Saliceto Polichirurgico Hospital   (Italy)

^b General Hospital of Brescia   (Italy)

^c CREMONA HOSPITAL   (Italy)

^d NONE   (Italy)

Author keywords

Angioplasty; Atherosclerotic renovascular disease; Cardio and cerebro vascular comorbidity; End stage renal disease; Hypertension; Ischemic nephropathy; Percutaneous transluminal renal artery stenting; Randomized controlled trial; Renal artery stenosis; Renal insufficiency

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OMEGA 3 FATTY ACID; TICLOPIDINE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIALYSIS; DISEASE CONTROL; DISEASE COURSE; DOPPLER ECHOGRAPHY; DYSLIPIDEMIA; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RENAL ARTERY; RENOVASCULAR DISEASE; STATISTICAL SIGNIFICANCE; STENT;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; ATHEROSCLEROSIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MAGNETIC RESONANCE ANGIOGRAPHY; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; RENAL ARTERY OBSTRUCTION; STENTS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 28244486500     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Goldblatt H. Studies on experimental hypertension, V: the pathogenesis of experimental hypertension due to renal ischemia. Ann Intern Med 1937; 11: 69-103.
2. Sawicki PT, Kaiser S, Heinemann L, Frenzel H, Berger M. Prevalence of renal artery stenosis in diabetes mellitus - an autopsy study. J Intern Med 1991; 229: 489-92.
3. Olin JW, Melia M, Young JR, Graor RA, Risius B. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med 1990; 88: N46-51.
4. Harding MB, Smith LR, Himmelstein SI, Harrison K, Phillips HR, Schwab SJ, Hermiller JB, Davidson CJ, Bashore TM. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol 1992; 2: 1608-16.
5. Scarpioni R, Bacchi M, Cristinelli L, Rosi A, Tarantino F, Cappucci A. Unsuspected detection of renal artery stenosis in patients undergoing diagnostic cardiac catheterisation. Am Soc Nephrol 32nd Annual Meeting in Miami 1999, A1868.
6. Scoble JE, Maher ER, Hamilton G, Dick R, Sweny P, Moorhead JF. Atherosclerotic renovascular disease causing renal impairment - a case for treatment. Clin Nephrol 1989; 31: 1191-202.
7. Mailloux L, Napolitano B, Bellucci AG, Vernace M, Wilkes BM, Mossey RT. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: A 20-year clinical experience. Am J Kidney Dis 1994; 24: 622-9.
8. Textor SC. Renovascular hypertension and ischemic nephropathy. In Brenner BM ed. Brenner and Rector's the kidney. Philadelphia: W.B. Saunders 2004; 2065-108.
9. Caps MT, Perissinotto C, Zierler RE, Polissar NL, Bergelin RO, Tullis MJ, Cantwell-Gab K, Davidson RG, Strandness DE Jr. Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998; 98: 2866-72.
10. Ritz E, Mann JF. Renal angioplasty for lowering blood pressure. N Engl J Med 2000; 342: 1042-3.
11. Conlon PJ, Little MA, Pieper K, Mark DB. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int 2001; 60: 1490-7.
12. Johansson M, Herlitz H, Jensen G, Rundqvist B, Friberg P. Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens. J Hypertens 1999; 17: 1743-50.
13. Webster J. Scottish, Newcastle Renovascular Collaborative Group: prospective, randomized trial of interventional angioplasty versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. Am J Hypertens 1995; 8; A38.
14. Plouin PF, Chatellier G, Darne B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998; 31: 823-9.
15. van Jaarsveld B, Krijnen P, Bartelink A, Dees A, Derkx F, Man in't Veld A, Schalekamp M. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale, design and inclusion data. J Hypertens 1998; 16(Suppl): S21-7.
16. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: A0828.
17. VII Report of the National Joint Committee on prevention, detection, evaluation and treatment of high blood pressure. May 2003. Available at: http://www.nhlbi.nih.gov/about/nhbpep/index.htm accessed December 1, 2004
18. Fried LF, Orchaard TJ, Kasiske B. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int 2001; 59: 260-9.
19. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180-4.
20. Schoenfeld DA. Sample-size formula for the proportional-hazards regression model. Biometrics 1983; 39: 499-503.
21. Lachin JM, Foulkes MA. Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification Biometrics 1986; 42: 507-19.
22. Tuttle KR, Chouinard RF, Webber JT, Dahlstrom LR Short R AT, Henneberry K, Dunham LA, Raabe RD. Treatment of atherosclerotic renal artery stenosis with the intravascular stent. Am J Kidney Dis 1998; 332: 611-22.
23. Harden PN, MacLeod MJ, Rodger RS, Baxter GM, Connell JM, Dominiczak AF, Junor BJ, Briggs JD, Moss JG. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 1997; 349: 1133-6.
24. Beutler JJ, Van Ampting JM, Van De Ven PJ, Koomans HA, Beek FJ, Woittiez AJ, Mali W. Long-term effects of arterial stenting on kidney function for patients with ostial atherosclerotic renal artery stenosis and renal insufficiency. J Am Soc Nephrol 2001; 12: 1475-81.
25. Safian R, Textor S. Renal Artery Stenosis. New Engl J Med 2001; 344: 431-42.
26. Woolfson RG. Renal failure in atherosclerotic renovascular disease: pathogenesis, diagnosis, and intervention. Postgrad Med J 2001; 77: 68-74.
27. Baboolal K, Evans C, Moore RH. Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renovascular disease. Am J Kidney Dis 1998; 31: 971-7.
28. Bax L, Mali W, Buskens E, Koomans HA, Beutler JJ. The benefit of stent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by atherosclerotic ostial stenosis of the renal artery. The STAR-study: rationale and study design. J Nephrol 2003; 16: 807-12.
29. Mikhail A, Cook GJ, Reidy J, Scoble JE. Progressive renal dysfunction despite successful renal artery angioplasty in a single kidney. Lancet 1997; 349: 926.
30. 2003 European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-53.